|
Volumn 20, Issue 1, 2002, Pages 53-57
|
Production of human clotting Factor IX without toxicity in mice after vascular delivery of a lentiviral vector
a a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
BODY FLUIDS;
CELLS;
PROTEINS;
TOXICITY;
VIRUSES;
LENTIVIRAL VECTORS;
GENE TRANSFER;
RECOMBINANT BLOOD CLOTTING FACTOR 9;
VIRUS VECTOR;
ANIMAL EXPERIMENT;
ANIMAL TISSUE;
ARTICLE;
CONTROLLED STUDY;
DNA MODIFICATION;
DRUG MANUFACTURE;
GENE TRANSFER;
HUMAN IMMUNODEFICIENCY VIRUS;
IN VIVO STUDY;
LENTIVIRINAE;
LIVER CELL;
MOUSE;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN BLOOD LEVEL;
PROTEIN EXPRESSION;
SAFETY;
TOXICITY;
ANIMALS;
BROMODEOXYURIDINE;
CELL DIVISION;
FACTOR IX;
GENE TRANSFER TECHNIQUES;
GENETIC VECTORS;
GREEN FLUORESCENT PROTEINS;
HEPATOCYTES;
IMMUNOHISTOCHEMISTRY;
KINETICS;
LENTIVIRUS;
LUMINESCENT PROTEINS;
MEMBRANE GLYCOPROTEINS;
MICE;
MICE, INBRED C57BL;
MICE, NUDE;
SPLEEN;
TIME FACTORS;
TRANSDUCTION, GENETIC;
TRANSGENES;
VIRAL ENVELOPE PROTEINS;
ANIMALIA;
HUMAN IMMUNODEFICIENCY VIRUS;
LENTIVIRUS;
RNA VIRUSES;
|
EID: 0036137639
PISSN: 10870156
EISSN: None
Source Type: Journal
DOI: 10.1038/nbt0102-53 Document Type: Article |
Times cited : (56)
|
References (25)
|